Achievement
Cagent Vascular Closes $41 Million Series D Financing With Guidance From Troutman Pepper Locke
PHILADELPHIA – Troutman Pepper Locke advised Cagent Vascular, Inc., a leader in endovascular technologies, in the closing of a $41 …
Delivering results that matter
Across our diverse practices, we have consistently delivered remarkable outcomes for our clients. Take a closer look at how we partner with clients to help them realize their goals.
Filter By:
Applied Filters:
Achievement
Troutman Pepper Locke Advises Climate Investment on Series B Financing in Membrane Technology & Research
HOUSTON – Troutman Pepper Locke represented Climate Investment, an independently managed specialist investor in decarbonization technologies, as lead investor in a $27 …
Achievement
Troutman Pepper Locke Advises Blue Heron Capital on Investment in Virtual Rheumatology Provider Remission Medical
RICHMOND – Troutman Pepper Locke represented Blue Heron Capital, an early-stage growth equity firm, in its investment in Remission Medical, Inc. …
Achievement
Troutman Pepper Locke Advises MindImmune in $30 Million Series A Financing
PROVIDENCE – Troutman Pepper Locke advised MindImmune Therapeutics, Inc., a Rhode Island-based company started at the University of Rhode Island, in securing …
Achievement
Troutman Pepper Locke Advises Luna Health in $23.6M Series A Financing
Troutman Pepper Locke advised Luna Health Inc., a medical device company pioneering a first-of-its-kind method of insulin delivery for insulin …
Achievement
Troutman Pepper Locke Advises VODA.ai in Series A Financing
PROVIDENCE – Troutman Pepper Locke advised VODA.ai, a Boston-based SaaS company that uses artificial intelligence to enhance decision-making for water …
Achievement
Troutman Pepper Locke Advises DataBahn in $17 Million Series A Financing
Troutman Pepper Locke advised DataBahn.ai, Inc., creator of a security-native data pipeline platform built for modern enterprise workloads, in raising …
Achievement
Troutman Pepper Locke Advises Via Science in $28 Million Series B Investment From Global Enterprises
Troutman Pepper Locke advised Via Science, Inc. (VIA), a leader in decentralized, enterprise-scale data and identity protection, in raising $28 …
Achievement
Troutman Pepper Locke Advises NewSpring Capital in $15M Investment in Insurance Software Firm
Troutman Pepper Locke represented NewSpring Capital in its $15 million Series B funding round supporting Jones, the vertical software company …
Achievement
Palvella Therapeutics Completes Reverse Merger with Pieris Pharmaceuticals and Concurrent Private Placement
Troutman Pepper represented Palvella Therapeutics, Inc. (NASDAQ: PVLA), a clinical-stage rare disease biopharmaceutical company, in the completion of its previously …
Achievement
Troutman Pepper Advises Alum-a-Lift in Sale to Piab Group
Troutman Pepper represented Alum-a-Lift, a creator, manufacturer, and world-leading provider of advanced technology consisting of innovative ergonomic lifting equipment, headquartered …
Achievement
Troutman Pepper Advises NewSpring in Closing of NewSpring Mezzanine Capital V
Troutman Pepper advised NewSpring, a family of private equity strategies, in the final close of NewSpring Mezzanine Capital V (the …